Lucida Medical Patents

Patent portfolio assigned to Lucida Medical (verified via public assignee records). Estimated patent count: 1. Cambridge, England medtech (Prostate Intelligence 'Pi' AI/ML prostate-cancer detection from MRI; CE marked; founders Dr Antony Rix, Prof Evis Sala, 2019/2020; deployed across NHS and 11 countries). Partners: Hampshire Hospitals NHS FT (validation study), University of Cambridge. CB Insights reports 1 patent filed; could not independently confirm a granted patent under Lucida Medical assignee on Google Patents/Justia, so count is low-confidence.